BRD2 Antikörper (AA 1-801)

Produktnummer ABIN948411

Produktdetails anti-BRD2 Antikörper

Target: BRD2 (Bromodomain Containing 2 (BRD2))

Bindungsspezifität: AA 1-801

Reaktivität: Human

Wirt: Maus

Klonalität: Polyklonal

Konjugat: Dieser BRD2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunofluorescence (IF)

Verwendungszweck: Mouse polyclonal antibody raised against a full-length human BRD2 protein.

Sequenz: MLQNVTPHNK LPGEGNAGLL GLGPEAAAPG KRIRKPSLLY EGFESPTMAS VPALQLTPAN PPPPEVSNPK KPGRVTNQLQ YLHKVVMKAL WKHQFAWPFR QPVDAVKLGL PDYHKIIKQP MDMGTIKRRL ENNYYWAASE CMQDFNTMFT NCYIYNKPTD DIVLMAQTLE KIFLQKVASM PQEEQELVVT IPKNSHKKGA KLAALQGSVT SAHQVPAVSS VSHTALYTPP PEIPTTVLNI PHPSVISSPL LKSLHSAGPP LLAVTAAPPA QPLAKKKGVK RKADTTTPTP TAILAPGSPA SPPGSLEPKA ARLPPMRRES GRPIKPPRKD LPDSQQQHQS SKKGKLSEQL KHCNGILKEL LSKKHAAYAW PFYKPVDASA LGLHDYHDII KHPMDLSTVK RKMENRDYRD AQEFAADVRL MFSNCYKYNP PDHDVVAMAR KLQDVFEFRY AKMPDEPLEP GPLPVSTAMP PGLAKSSSES SSEESSSESS SEEEEEEDEE DEEEEESESS DSEEERAHRL AELQEQLRAV HEQLAALSQG PISKPKRKRE KKEKKKKRKA EKHRGRAGAD EDDKGPRAPR PPQPKKSKKA SGSGGGSAAL GPSGFGPSGG SGTKLPKKAT KTAPPALPTG YDSEEEEESR PMSYDEKRQL SLDINKLPGE KLGRVVHIIQ AREPSLRDSN PEEIEIDFET LKPSTLRELE RYVLSCLRKK PRKPYTIKKP VGKTKEELAL EKKRELEKRL QDVSGQLNST KKPPKKANEK TESSSAQQVA VSRLSASSSS SDSSSSSSSS SSSDTSDSDS G

Kreuzreaktivität: Human

Produktmerkmale: Antibody reactive against mammalian transfected lysate.

Immunogen: BRD2 (NP_005095.1, 1 a.a. ~ 801 a.a) full-length human protein.

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Buffer: In 1x PBS, pH 7.4

Handhabung: Aliquot to avoid repeated freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.

Details zu BRD2

Target: BRD2 (Bromodomain Containing 2 (BRD2))

Andere Bezeichnung: BRD2 (BRD2 Produkte)

Synonyme: D6S113E antikoerper, FSH antikoerper, FSRG1 antikoerper, NAT antikoerper, RING3 antikoerper, RNF3 antikoerper, AW228947 antikoerper, D17H6S113E antikoerper, Frg-1 antikoerper, Fsrg-1 antikoerper, Fsrg1 antikoerper, Nat antikoerper, Ring3 antikoerper, Rnf3 antikoerper, mKIAA4005 antikoerper, brd2-a antikoerper, fsh antikoerper, fsrg1 antikoerper, nat antikoerper, ring3 antikoerper, rnf3 antikoerper, brd2 antikoerper, fe47f02 antikoerper, fi85h05 antikoerper, wu:fe47f02 antikoerper, wu:fi85h05 antikoerper, Ring3 protein antikoerper, bromodomain containing 2 antikoerper, bromodomain containing 2 S homeolog antikoerper, bromodomain containing 2a antikoerper, CHLREDRAFT_190116 antikoerper, CHLREDRAFT_150233 antikoerper, CHLREDRAFT_182576 antikoerper, CHLREDRAFT_188250 antikoerper, BRD2 antikoerper, Brd2 antikoerper, brd2.S antikoerper, brd2a antikoerper

Hintergrund: Full Gene Name: bromodomain containing 2
Synonyms: D6S113E,DKFZp686N0336,FLJ31942,FSH,FSRG1,KIAA9001,NAT,RING3,RNF3

Gen-ID: 6046

NCBI Accession: NM_005104

Pathways: Chromatin Binding, SARS-CoV-2 Protein Interaktom, Phosphorylierungen bei SARS-CoV-2 Infektion